Track topics on Twitter Track topics that are important to you
Scientists at MIT have developed a new model which can predict whether patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline, by predicting their cognitive test scores up to two years in the future.
The model could be used to improve the selection of candidate drugs and participant cohorts in clinical trials, while also allowing patients to know they might experience rapid cognitive decline in the coming months and years, so they and their loved ones can prepare.NEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...